Outcome of Primary Bone Fragment Replacement in Pediatric Patients with Depressed Skull Fracture

Kadir Oktay1, Ebru Guzel2, Emre Unal3

  • 1Department of Neurosurgery, Gaziantep Medical Park Hospital, Gaziantep, Turkey, drkadiroktay@hotmail.com.

Pediatric Neurosurgery
|January 24, 2019
PubMed

Insights

Primary bone fragment replacement is an effective treatment for pediatric depressed skull fractures, yielding good outcomes and low infection rates when performed promptly. Early surgical intervention reduces contamination risks and improves patient results.

Area of Science:

  • Pediatric Neurosurgery
  • Traumatic Brain Injury Management
  • Surgical Reconstruction

Background:

  • Depressed skull fractures in children require effective surgical management.
  • Assessing outcomes of surgical repair in pediatric patients is crucial for optimizing treatment protocols.
  • Understanding the impact of associated injuries on outcomes is essential.

Purpose of the Study:

  • To evaluate the outcomes of pediatric patients surgically treated for depressed skull fractures.
  • To assess the efficacy of primary bone fragment replacement in this patient population.
  • To identify factors influencing surgical outcomes in pediatric depressed skull fractures.

Main Methods:

  • Retrospective review of 78 pediatric patients with depressed skull fractures treated between 2002 and 2018.
  • All patients underwent primary bone fragment replacement using their own bone flaps.
  • Data analysis included injury severity, dural status, surgical outcomes, and complications.

Main Results:

  • 81% of patients achieved a good outcome post-surgery.
  • The mortality rate was 2.5%, primarily in patients with multiple cranial pathologies.
  • Infection rates were low (2.5%), with no cases of osteomyelitis or deep-seated infections.

Conclusions:

  • Primary bone fragment replacement is a successful treatment for pediatric depressed skull fractures.
  • Prompt surgical intervention, ideally within 72 hours, minimizes contamination risk.
  • Increased accompanying pathologies correlate with lower Glasgow Coma Scale and Glasgow Outcome Scale scores.
Abstract

Related Concept Videos

Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
5.4K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
259
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
223
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
292
Habitat Fragmentation02:31

Habitat Fragmentation

Habitat fragmentation describes the division of a more extensive, continuous habitat into smaller, discontinuous areas. Human activities such as land conversion, as well as slower geological processes leading to changes in the physical environment, are the two leading causes of habitat fragmentation. The fragmentation process typically follows the same steps: perforation, dissection, fragmentation, shrinkage, and attrition.
21.4K